India Says Counterfeit Drugs Should Be Handled By WTO - Not WHO
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs
You may also be interested in...
EU And India Bury Hatchet Over Drug Seizures But Companies Fear ACTA May Bring More Pains
MUMBAI - Leading pharmaceutical lobby groups - the Indian Drug Manufacturers Association and the Indian Pharmaceutical Alliance - cautiously welcomed the resolution of a trade dispute with the European Union that for more than two years saw random seizure of several generic drug consignments from Indian companies at select European ports
EU And India Bury Hatchet Over Drug Seizures But Companies Fear ACTA May Bring More Pains
MUMBAI - Leading pharmaceutical lobby groups - the Indian Drug Manufacturers Association and the Indian Pharmaceutical Alliance - cautiously welcomed the resolution of a trade dispute with the European Union that for more than two years saw random seizure of several generic drug consignments from Indian companies at select European ports
IFPMA Outlines Plan For Fighting Counterfeit Drugs
HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem